Prana Biotechnology Investor Presentation and Audio Recording – Phase 2 HD trial February 18, 2014August 16, 2022
Further Information – Prana’s PBT2 Clinical Trials Cited as Most Advanced in Addressing Neurodegeneration from the Metal Equilibrium Perspective July 17, 2013August 16, 2022
Alterity Therapeutics Announces New Publications Providing Further Evidence of the Potential of ATH434 to Treat Neurodegenerative Diseases November 4, 2021August 16, 2022